Nhungamiro yehunyanzvi

ADMET and Toxicity Prediction

ADMET prediction estimates absorption, distribution, metabolism, excretion, and toxicity properties from molecular structure or other data.

Teerera kugwaro iriAI-yakarondedzerwa · ~3 min

Pa peji ino3 min verenga
  1. Pfupiso
  2. Kudzika Kwakadzika
  3. Kuitwa muNyika yeChokwadi
  4. The Future of ADMET and Toxicity Prediction
  5. Kuzvishandisa
  6. Ramba Uchiongorora
  7. Mibvunzo inowanzo bvunzwa

Pfupiso

These models can help prioritize compounds for experiments, but predictions are endpoint-specific and require domain-aware validation rather than being treated as proof of safety or drug suitability.

Kudzika Kwakadzika

ADMET is a collection of pharmacokinetic and safety properties: absorption, distribution through the body, metabolism, excretion, and toxicity. Different endpoints measure different biological processes, such as solubility, permeability, plasma protein binding, metabolic stability, clearance, or a particular toxicity assay. There is no single ADMET score that proves a compound is suitable for humans. Machine-learning models learn from experimental datasets or curated databases using molecular fingerprints, descriptors, graphs, or learned representations. Labels can be noisy because assays vary in protocol, cell line, organism, concentration, and measurement units. Some datasets combine values from different sources or convert continuous measurements into categories. Endpoint definitions and unit conversions should be checked before training. Evaluation must reflect the intended use. Random splits can place close analogs in training and test sets, making prediction easier than for new chemical scaffolds. Scaffold-based, temporal, or external splits can better probe generalization, depending on the question. Class imbalance, censored values, repeated compounds, and assay leakage also need attention. Report uncertainty and the model's applicability domain: whether a candidate resembles the chemistry and conditions used for training. A positive model prediction is a hypothesis for follow-up, not experimental evidence. Use models to prioritize tests, compare with baselines, and identify compounds where predictions are uncertain or endpoints disagree. High-stakes toxicology decisions require appropriate assays and expert review. A model trained on one endpoint cannot establish broader safety or human outcomes. OECD guidance on QSAR model validation emphasizes a defined endpoint, unambiguous algorithm, defined applicability domain, appropriate measures of goodness-of-fit and predictivity, and mechanistic interpretation where possible. These principles help make structure-activity predictions more transparent. Maintain data provenance and versioning so predictions can be traced to assays, structures, and model configurations.

Kuitwa muNyika yeChokwadi

A discovery team ranks compounds by a predicted solubility endpoint and sends selected structures for an appropriate laboratory assay.

A toxicology group checks whether a new molecule lies within the chemistry domain represented by its training compounds.

An analyst distinguishes predictions for liver metabolism from separate endpoints for cardiac, genetic, or acute toxicity.

A model report includes assay source, endpoint definition, uncertainty, and an external evaluation split.

The Future of ADMET and Toxicity Prediction

ADMET models may improve as datasets capture richer assay context, chemical domains, and uncertainty. Integrating predictions across endpoints could help prioritize experiments, but it can also hide disagreements if combined into one score. Regulatory and scientific practice will continue to require transparent validation and domain limits. Experimental assays and expert review will remain central to safety assessment. Better assay context may improve transfer between datasets, but endpoint definitions will remain important. New models should report uncertainty and chemical scope so experimental teams can choose appropriate follow-up.

Kuzvishandisa

Nei zvichikosha

  • Mutengo uye bhajeti. Zvisarudzo zvezvivakwa zvinotyaira kuita uye mutengo wekushandisa kwemakore.
  • Sarudzo dzakajeka. Dzidzo yehunyanzvi inobatsira zvikwata kusarudza murwi wakakodzera, kwete iwo mutsva chete.
  • Kudzora kwemhando yepamusoro. Sarudzo dzeinjiniya dziri nani dzinoderedza zviitiko zvekuvimbika mukugadzira.

Chenjera

  • Kugadzirisa imwe bhenji kunogona kuvanza yakafara system kushaya simba.
  • Infrastructure uye mari yekugadzirisa inowanzotarisirwa pasi.
  • Chengetedzo uye kucherechedzwa mapundu anogona kukura sezvo masisitimu anowedzera kuoma.

Matanho anotevera

  1. Tsanangura latency, mhando, uye mutengo zvinangwa usati waitwa.
  2. Benchmark pasi pechokwadi mutoro uye data mamiriro.
  3. Chishandiso chekutarisa zvikanganiso, kudonha, uye mushandisi maitiro.
  4. Gadzirira nzira dzekudzosera kumashure uye dzezviitiko usati wawedzera.

Ramba Uchiongorora

Tsamba yemahara

Tora iyo yemazuva ese AI pfupiso

Nhatu dzakasimbiswa dzeAI nyaya mangwanani ega ega pakati pevhiki, dzakanyorwa neChirungu chakajeka. Yemahara zvachose, hapana ads.

Imwe email zuva rega rega revhiki. Bvisa kunyoresa kamwe chete. Hatimbotengese kana kugovera kero yako.

Zviedze iwe pachako

Take the ADMET and Toxicity Prediction quiz

Mhinduro yepakarepo pamhinduro yega yega, uye chitupa chinogovaniswa chine ID inobatika kana wapedza kosi.

Tanga mibvunzo

Tsigira dzidzo yemahara yeAI. AI Understanding ndeye 501(c)(3) isingabatsiri - hapana ads, hapana paywall, zvachose. Ita chipo

Mibvunzo inowanzo bvunzwa

What is ADMET and Toxicity Prediction?

ADMET prediction estimates absorption, distribution, metabolism, excretion, and toxicity properties from molecular structure or other data. These models can help prioritize compounds for experiments, but predictions are endpoint-specific and require domain-aware validation rather than being treated as proof of safety or drug suitability.

Why are ADMET predictions endpoint-specific?

Solubility, clearance, permeability, and toxicity are different endpoints.

Why can a random molecular split overstate performance on new chemical scaffolds?

Close structures across partitions can make test predictions easier.

What does an applicability domain describe?

Applicability domain indicates whether a candidate resembles the model's training conditions.

Why document assay source and protocol with training labels?

Assay variation and endpoint definitions affect label consistency.

What does a positive predicted safety result establish?

Predictions are not equivalent to experimental or clinical evidence.